small molecule HSF1 activators (Chaperone Therapeutics)

N/A

Report date: 2025/03/20 14:42:55
NME

Base Information

Drug Namesmall molecule HSF1 activators (Chaperone Therapeutics)
Drug Alias Namesmall molecule protein aggregation suppressors (Chaperone Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock factor protein 1 stimulants
TargetsHeat shock factor protein 1
Therapy Area/IndicationsNerve DegenerationGlycogen Storage DiseaseHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChaperone Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNerve DegenerationGlycogen Storage DiseaseHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A